U
UZ Gent | Polikliniek - Reumatologie Department
Research site
(Unclaimed)
Site insights
Top conditions
Top treatments
Vericiguat
MK-6194
MK-1242-036
MK-6194-007
Data sourced from clinicaltrials.gov
Work at this site?
CTV for research professionals allows users to enhance their site’s profile, add contact information, and more.
Active trials
3 of 4 total trials
Researchers are looking for a new way to treat people with non-segmental vitiligo (NSV). The goal of this study is to learn about the safety of MK-61...
Enrolling
Non-segmental Vitiligo
Biological: MK-6194
Drug: Placebo
The purpose of this study is to learn if V940 which is an individualized neoantigen therapy (INT; formerly, called messenger ribonucleic acid \[mRNA\...
Enrolling
Melanoma
Biological: Pembrolizumab
Biological: V940
This study aims to compare the efficacy of vericiguat versus placebo on change in n-terminal pro-brain natriuretic peptide (NTproBNP) from baseline t...
Enrolling
Left Ventricular Systolic Dysfunction
Heart Failure
Drug: Vericiguat tablet
Drug: Placebo tablet
Trial sponsors
Clinical trials
Research sites
Resources
Legal
© Copyright 2024 Veeva Systems